Company: RNGE
Filing Date: 2025-03-31
Form Type: 424B3
Source: 0001641172-25-001863
Chunk: 53

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 424B3
Chunk 53
---
 shares of common stock, all of which became fully exercisable in December 2021, and (iv) an option to purchase 250,000 shares of       
 common stock, all of which became fully exercisable in November 2022.                                                                  |

Compensation of Directors

Directors receive a combination of cash and equity awards as compensation for their service. There are no additional fees paid for meetings attended although our directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our Board of Directors and committees.

| 36 |

Director Compensation Table

The following table shows compensation paid to our non-employee directors during the year ended December 31, 2024:

| Name                |     | Fees         
 earned or    
 paid in cash |         |     | Option awards 
 (non-cash)(1) |   |     | All                
 other compensation |   |     | Total |         |
|:--------------------|:----|:-------------|--------:|:----|:--------------|:--|:----|:-------------------|:--|:----|:------|--------:|
| Richard Celeste (1) |     | $            |  36,000 |     | $             | - |     | $                  | - |     | $     |  36,000 |
| Edward Feighan (1)  |     | $            | 136,000 |     | $             | - |     |                    | - |     | $     | 136,000 |

| (1) | As                                                                                                                                           
 of December 31, 2024, the aggregate number of stock and option awards held by each of our non-employee directors was as follows:             
 (i) Mr. Celeste held an option award to purchase 500,000 shares of our common stock with an exercise price of $0.35 per share, an            
 option to purchase 250,000 shares of our common stock with an exercise price of $0.277 per share, an option to purchase 250,000 shares       
 of our common stock with an exercise price of $0.18 per share, and an option to purchase 250,000 shares of our common stock with             
 an exercise price of $0.18 per share, all of which are fully vested, and (ii) Mr. Feighan held an option award to purchase 500,000           
 shares of our common stock with an exercise price of $0.